Matches in SemOpenAlex for { <https://semopenalex.org/work/W2321859266> ?p ?o ?g. }
Showing items 1 to 82 of
82
with 100 items per page.
- W2321859266 endingPage "555" @default.
- W2321859266 startingPage "552" @default.
- W2321859266 abstract "Macular edema resulting from central retinal vein occlusion is effectively treated with anti-vascular endothelial growth factor injections. However, some patients need monthly retreatment and still show frequent recurrences. The purpose of this study was to evaluate the visual and anatomic outcomes of refractory macular edema resulting from ischemic central retinal vein occlusion in patients switched from ranibizumab to aflibercept intravitreal injections.We describe a retrospective series of patients followed in the Medical Retina Unit of the Jules Gonin Eye Hospital for macular edema due to ischemic central retinal vein occlusion, refractory to monthly retreatment with ranibizumab, and changed to aflibercept. Refractory macular edema was defined as persistence of any fluid at each visit one month after last injection during at least 6 months. All patients had to have undergone pan-retinal laser scan.Six patients were identified, one of whom had a very short-term follow-up (excluded from statistics). Mean age was 57±12 years. The mean changes in visual acuity and central macular thickness from baseline to switch were +20.6±20.3 ETDRS letters and -316.4±276.6 µm, respectively. The additional changes from before to after the switch were +9.2±9.5 ETDRS letters and -248.0±248.7 µm, respectively. The injection intervals could often be lengthened after the switch.Intravitreal aflibercept seems to be a promising alternative treatment for macular edema refractory to ranibizumab in ischemic central retinal vein occlusion." @default.
- W2321859266 created "2016-06-24" @default.
- W2321859266 creator A5020750527 @default.
- W2321859266 creator A5028376450 @default.
- W2321859266 creator A5037823975 @default.
- W2321859266 creator A5048711430 @default.
- W2321859266 date "2015-04-22" @default.
- W2321859266 modified "2023-09-27" @default.
- W2321859266 title "The Effect of Switching Ranibizumab to Aflibercept in Refractory Cases of Macular Edema Secondary to Ischemic Central Vein Occlusion" @default.
- W2321859266 doi "https://doi.org/10.1055/s-0035-1545783" @default.
- W2321859266 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25902119" @default.
- W2321859266 hasPublicationYear "2015" @default.
- W2321859266 type Work @default.
- W2321859266 sameAs 2321859266 @default.
- W2321859266 citedByCount "19" @default.
- W2321859266 countsByYear W23218592662016 @default.
- W2321859266 countsByYear W23218592662017 @default.
- W2321859266 countsByYear W23218592662018 @default.
- W2321859266 countsByYear W23218592662019 @default.
- W2321859266 countsByYear W23218592662020 @default.
- W2321859266 countsByYear W23218592662021 @default.
- W2321859266 crossrefType "journal-article" @default.
- W2321859266 hasAuthorship W2321859266A5020750527 @default.
- W2321859266 hasAuthorship W2321859266A5028376450 @default.
- W2321859266 hasAuthorship W2321859266A5037823975 @default.
- W2321859266 hasAuthorship W2321859266A5048711430 @default.
- W2321859266 hasConcept C118487528 @default.
- W2321859266 hasConcept C121332964 @default.
- W2321859266 hasConcept C141071460 @default.
- W2321859266 hasConcept C142424586 @default.
- W2321859266 hasConcept C2776268601 @default.
- W2321859266 hasConcept C2776694085 @default.
- W2321859266 hasConcept C2777802072 @default.
- W2321859266 hasConcept C2778257484 @default.
- W2321859266 hasConcept C2778749236 @default.
- W2321859266 hasConcept C2778844676 @default.
- W2321859266 hasConcept C2780261187 @default.
- W2321859266 hasConcept C2780347916 @default.
- W2321859266 hasConcept C2780827179 @default.
- W2321859266 hasConcept C2781100027 @default.
- W2321859266 hasConcept C2908732032 @default.
- W2321859266 hasConcept C71924100 @default.
- W2321859266 hasConcept C87355193 @default.
- W2321859266 hasConceptScore W2321859266C118487528 @default.
- W2321859266 hasConceptScore W2321859266C121332964 @default.
- W2321859266 hasConceptScore W2321859266C141071460 @default.
- W2321859266 hasConceptScore W2321859266C142424586 @default.
- W2321859266 hasConceptScore W2321859266C2776268601 @default.
- W2321859266 hasConceptScore W2321859266C2776694085 @default.
- W2321859266 hasConceptScore W2321859266C2777802072 @default.
- W2321859266 hasConceptScore W2321859266C2778257484 @default.
- W2321859266 hasConceptScore W2321859266C2778749236 @default.
- W2321859266 hasConceptScore W2321859266C2778844676 @default.
- W2321859266 hasConceptScore W2321859266C2780261187 @default.
- W2321859266 hasConceptScore W2321859266C2780347916 @default.
- W2321859266 hasConceptScore W2321859266C2780827179 @default.
- W2321859266 hasConceptScore W2321859266C2781100027 @default.
- W2321859266 hasConceptScore W2321859266C2908732032 @default.
- W2321859266 hasConceptScore W2321859266C71924100 @default.
- W2321859266 hasConceptScore W2321859266C87355193 @default.
- W2321859266 hasIssue "04" @default.
- W2321859266 hasLocation W23218592661 @default.
- W2321859266 hasLocation W23218592662 @default.
- W2321859266 hasOpenAccess W2321859266 @default.
- W2321859266 hasPrimaryLocation W23218592661 @default.
- W2321859266 hasRelatedWork W1965030185 @default.
- W2321859266 hasRelatedWork W1972614420 @default.
- W2321859266 hasRelatedWork W1997095687 @default.
- W2321859266 hasRelatedWork W2298380539 @default.
- W2321859266 hasRelatedWork W2578851731 @default.
- W2321859266 hasRelatedWork W2588621177 @default.
- W2321859266 hasRelatedWork W2987392209 @default.
- W2321859266 hasRelatedWork W3031005433 @default.
- W2321859266 hasRelatedWork W4205243730 @default.
- W2321859266 hasRelatedWork W4206282206 @default.
- W2321859266 hasVolume "232" @default.
- W2321859266 isParatext "false" @default.
- W2321859266 isRetracted "false" @default.
- W2321859266 magId "2321859266" @default.
- W2321859266 workType "article" @default.